Patents
Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
09/2011
09/21/2011EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
09/20/2011US8022234 Compounds and compositions
09/14/2011CN102180928A 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof
09/14/2011CN101759740B Method for synthesizing 3-alpha-acetoxy-deoxidized androstane-5-17-ketone
09/09/2011WO2011108661A1 Method for producing silylenol ethers
09/08/2011US20110218162 15-thia steroid compounds and compositions
09/07/2011CN102175750A Method for analyzing biological samples by using matrix assisted laser desorption ionization-Fourier transform ion cyclotron resonance mass spectra
08/2011
08/18/2011WO2011098439A2 A process for introducing a double bond into position 15,16 of a steroid
08/18/2011US20110201585 The Use of Oestrogen Applied to the Penis to Reduce HIV Infections
08/18/2011CA2787588A1 A process for introducing a double bond into position 15,16 of a steroid
08/17/2011CN101218245B 3-ester prodrugs of ethynylestradiol
08/11/2011US20110195942 Method of making and using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate
08/10/2011EP2354150A1 Process for the preparation of gestodene
08/09/2011US7994351 Preparation of bile acids and intermediates thereof
08/04/2011US20110190505 Iodonium Cyclophanes for SECURE Arene Functionalization
08/04/2011DE102010006818A1 Producing drospirenone, useful as hormonal contraceptives, by oxidatively converting hydroxy-dimethylenandrostane-one to hydroxy-dimethylenandrostan-dione, eliminating hydroxy group, followed by reacting with 1-halopropan-3-oxy
08/03/2011EP2350111A1 Processes and intermediates for the production of fulvestrant
08/02/2011US7989436 Estrogenic compounds and pharmaceutical formulations comprising the same
07/2011
07/28/2011US20110183949 Use of Fulvestrant in the Treatment of Resistant Breast Cancer
07/27/2011CN101445541B N-(methylthio-sulfur carbonyl)-17-steroidal hydrazone compound, preparation and application thereof
07/27/2011CN101160160B A process for the isolation of pharmacologically active principles of vegetable and animal origin
07/26/2011US7985848 Antidiabetic agent, blood glucose control abnormality; ginsenosides Rg3, Rg5, and Rk1 from natural substances
07/26/2011US7985744 Vitamin D derivatives
07/21/2011US20110178052 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer
07/20/2011EP2344515A1 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
07/20/2011CN102127137A Intermediate compound for use in preparation of androst amino acid ester and synthesis method thereof
07/19/2011CA2487722C New etonogestrel esters
07/05/2011US7973185 Process for the preparation of phenolic hydroxy-substituted compounds
06/2011
06/30/2011US20110160442 Method for the fractionation of knotwood extract and use of a liquid-liquid extraction for purification of knotwood extract
06/30/2011US20110158947 Sulfonylurea receptor and means for treating ischaemia
06/28/2011CA2529009C Method for obtaining a natural mixture of conjugated equine estrogens
06/23/2011US20110152552 Preparation of bile acids and intermediates thereof
06/23/2011US20110152544 Process for the preparation 2-substituted derivatives of estrone and estradiol
06/22/2011CN101296936B Process for production of steroid compound
06/21/2011US7964586 by solid phase extraction from pregnant mares urine; contacting the urine with polymeric adsorption resins sufficient to adsorb the estrogen derivatives in the urine, then separating the resulting resin loaded with the mixture, washing and eluting the derivatives
06/16/2011US20110144363 Process for obtaining 17-spirolactones in steriods
06/16/2011US20110144072 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants
06/16/2011US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs
06/09/2011US20110137057 Unsaturated Steroid Compounds
06/03/2011WO2011066542A2 6-substituted estradiol derivatives and methods of use
06/03/2011CA2781627A1 6-substituted estradiol derivatives and methods of use
06/02/2011US20110130581 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
06/02/2011US20110130580 Use of buckysome or carbon nanotube for drug delivery
05/2011
05/26/2011US20110124894 Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
05/25/2011CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity
05/19/2011US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
05/18/2011EP2322182A1 Androstenol derivatives as androgen receptor modulator
05/18/2011EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
05/18/2011CN102060886A Method for preparing 4, 6-dibenzyl-2, 3-unsaturated glucoside
05/18/2011CN101537344B Monolithic column, preparation method and application thereof
05/17/2011CA2411409C Vitamin d derivatives
05/11/2011CN102050858A Preparation method of 17-prasterone androstane-4-alkene-3-ketone
05/10/2011CA2450359C Dosage regimen and pharmaceutical composition for emergency contraception
05/10/2011CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides
05/04/2011CN102040640A Method for purifying dihydrosarcostin by high-speed counter-current chromatography
05/04/2011CN102040639A Methods for preparing fluoxymesterone and intermediate thereof
05/03/2011US7935838 Process for production of steroid compound
04/2011
04/28/2011WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases
04/28/2011US20110098260 Steroid Compounds and Formulations
04/27/2011CN102030797A Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof
04/27/2011CN101362788B High-efficiency synthesis method of 6 alpha-bromo-carboxyandrost-4-ene-3,17-dione
04/20/2011EP2311465A1 Remedies for diseases to be applied to eye
04/20/2011CN101440112B Steroid compound and use thereof
04/19/2011CA2529669C Method for measuring aromatase activity
04/19/2011CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens
03/2011
03/30/2011EP2301549A1 Remedies for diseases to be applied to eye
03/30/2011CN101061132B Method for preparing 17- hydroxy- 6beta, 7beta, 15beta, 16beta- bisacrylamide- 17alpha- pregnane- 4- ene- 3- ketone- 21- carboxylate gamma- lactone and key intermediate used for the said method
03/24/2011US20110071095 Compositions and Methods for Increasing Telomerase Activity
03/23/2011EP2069382B1 Process for the selective isolation, purification and separation of monohydroxylated 3,17-diketo-steroid compounds
03/22/2011US7910756 Process for the preparation 2-substituted-derivatives of estrone and estradiol
03/22/2011US7910755 Stem cell expansion and uses
03/15/2011US7906497 Cancer treatment methods
03/09/2011EP2292239A2 Remedies for diseases to be applied to eye
03/09/2011EP1622925B1 Novel method and intermediates for the preparation of 19-nor-steroid compounds
03/08/2011US7901904 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
03/02/2011CN101982472A Synthesis process of levonorgestrel by methoxydienone
02/2011
02/24/2011US20110046599 Multi-Day Delivery Of Biologically Active Substances
02/24/2011US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds
02/22/2011US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase
02/22/2011CA2446314C Liver x receptor agonists
02/16/2011EP2284176A1 Process for preparing guggulsterones and guggulsterol
02/16/2011EP2283865A1 Method of increasing testosterone and related steroid concentrations in women
02/16/2011EP2283025A1 5-fluoro-3 ,17 -dihydroxy-5 -androstan-6-one, the method for its production and its use for influencing of plant growth
02/10/2011US20110034429 5a-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR
02/09/2011CN101089011B Process of producing methyltestosterone with Grignard reagent as material
02/08/2011US7884222 Process for the production of tibolone
02/03/2011US20110028711 Unsaturated Steroid Compounds
01/2011
01/27/2011WO2011009529A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases
01/27/2011CA2768448A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases
01/26/2011CN101353365B Preparation of progestational hormone
01/25/2011CA2441834C Lipid profile modulation
01/20/2011US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity
01/19/2011EP2274316A1 Ligands of estrogen receptors and , method of their preparation and pharmaceuticals comprising them
01/19/2011CN101948495A Preparation method of compound 19-desmethyl-4-androstene-3,17 diketone
01/13/2011US20110009654 11b-fluoro-3-acetoxyestra-3,5-dien-17-one and method for the production thereof
01/11/2011US7868193 Contraceptives; hormone replacement therapy
01/05/2011EP2268655A2 Birch reduction of steroid substrates via alkali metal-silica gel materials
01/04/2011US7863261 androgen receptor modulator; analogs of androst-5-ene-3 beta ,17 beta -diol ("AED") or 1,3,5(10)-estratriene-17 alpha -ethynyl-3 beta ,17 beta -diol ("EED")
01/04/2011CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them
12/2010
12/30/2010US20100331268 Nitrated Lipids and Methods of Making and Using Thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 49